Evidence map›Paper›PMID 41795975›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Positive antinuclear antibodies suggest a high inflammatory burden phenotype: a multicenter retrospective analysis of patients with primary biliary cholangitis].

S S Li, R J Li, Y Zhang, W J Ji, Y J Bao, H L Liu, Y X Gong, Y T Wang, Y L Tao, Z X Wu and 9 more

Abstract readMulticenter StudyEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

S S LiThe Second Hospital of Nanjing, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing 210003,China.
R J LiNanjing Medical University School of Public Health, Nanjing 210003,China.
Y ZhangDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
W J JiDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Y J BaoDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
H L LiuDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Y X GongDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Y T WangDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Y L TaoDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Z X WuDepartment of Hepatobiliary Disease, 900th Hospital of Joint Logistics Support Force, Fuzhou 350025, China.
Y ZhangThe First Department of Hepatology, the Fourth People's Hospital of Qinghai Province, Xining 810000, China.
W H ZhangHepatobiliary Center, Wuwei Tumor Hospital of Gansu Province, Wuwei 733000, China.
W LiDepartment of Gastroenterology, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China.
F YeDepartment of Infectious Diseases, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
X H YanDepartment of Liver Disease, Lanzhou Second People's Hospital, Lanzhou 730046, China.
T H MaoDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
X LiuDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
K ZhangDepartment of Infectious Disease and Liver Disease , the Second Hospital of Nanjing , Affiliated to Nanjing University of Chinese Medicine, Nanjing 210003,China.
Y F YangThe Second Hospital of Nanjing, Clinical Teaching Hospital of Medical School, Nanjing University, Nanjing 210003,China.

Funding

Natural Science Foundation of Jiangsu Province of China BK20251727
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antibodies, AntinuclearLiver Cirrhosis, BiliaryAgedAlkaline PhosphataseFemalegamma-GlutamyltransferaseHumansInflammationMaleMiddle AgedPhenotypePrognosisRetrospective StudiesAlkaline PhosphataseAntibodies, Antinucleargamma-Glutamyltransferase

Identifiers

PMID41795975
PMCPMC12963859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.